Search

How Can We Help You?

Video

Quick Info:

Find a Doctor Specialties (800) 213-3284

Select Clinical Trial

Protocol Number: EA2176

Protocol Title: A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naïve Metastatic Anal Cancer Patients

Eligibility: Patient must have inoperable, recurrent, or metastatic disease not amenable to curative therapy, confirmation of anal squamous cell carcinoma

Contact Information: (910) 715-2200

 

 

Specialties
Clara McLean House
Make a Donation
News & Events